Where does Probiotical S.P.A. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Probiotical S.P.A. ranks #10,727 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Probiotical S.P.A. hold?

Probiotical S.P.A. holds 29 US utility patents granted between 2015 and 2025, spanning 7 technology areas.

What is Probiotical S.P.A.'s Innovation Score?

Probiotical S.P.A. has an Innovation Score of 32.2 out of 100 (40th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Probiotical S.P.A. focus on?

Probiotical S.P.A.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 27 patents, ranking #737 of 6,058 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Probiotical S.P.A.'s patent grant rate increasing or decreasing?

Probiotical S.P.A.'s recent grant velocity is +45% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Probiotical S.P.A.'s patents?

Probiotical S.P.A.'s patents average 11.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Probiotical S.P.A. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Probiotical S.P.A.

USPTO PatentsView assignee record - 29 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Probiotical ranks #10,727 of 49,997 tracked US assignees by granted-patent volume, with 29 patents across 7 technology areas.

#10,727
of 49,997 US assignees by volume: 40th percentile
by Innovation Score (32.2/100): 11.4
avg claims per patent: +45%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10727 · Foreign Corporation #10,727 · 29 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 29 grants
UPPER-Q #10,727/49,997
PHOTO-FINISH Palo Alto Investors
CPC-NARROW A61P · 7 areas
INNOV-THIN 32.2/100
CLAIMS-PAR 11.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +45% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Palo Alto Investors LP (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Probiotical’s 32.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.7 pts (36%) Velocity 4.2 pts (13%) Breadth 9.4 pts (29%) Claim depth 6.9 pts (21%)

Qualcomm Incorporated · highest

85
Henan Genuine Biotech · near

32
Probiotical S P A · this assignee

32
Redpine Signals · near

32
FlowCardia · near

32
Hangzhou Biotest… · near

32
3D Lighting… · lowest

7

What this shows Probiotical's Innovation Score is 32.2/100 (40th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Probiotical?

Each dot is one of Probiotical’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Probiotical’s own 11.4 claims/patent is at or below the 15.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Probiotical vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Probiotical's grants concentrate

Probiotical S.P.A. is a focused PatentsView assignee: 7 CPC subclasses with 93.1% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (9 grants) versus a trough of 1 in 2015. By volume, Probiotical sits between PB Inc. and Prüftechnik Dieter Busch GmbH.

Probiotical's three-year grant acceleration

Probiotical S.P.A. shows 7 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

PB

29
Pctel

29
Pegavision

29
Powdermet

29
Protalus

29
Palo Alto Investo…

29
Phazr

29
Prüftechnik Diete…

29
Probiotical S P A ◀

29

What this shows Probiotical holds 29 patents at rank #10,724, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Probiotical

By rank, the assignees closest to #10,724 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Probiotical's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Probiotical, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Probiotical ranks #737 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (32 here).

Redpine Signals, Inc. 32 Henan Genuine Biotech Co., Ltd. 32 FlowCardia, Inc. 32 Hangzhou Biotest Biotech Co., Ltd. 32

Probiotical's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 40th percentile higher than 40% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Probiotical S.P.A. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	3.4%
2016	4	13.8%
2017	1	3.4%
2018	3	10.3%
2019	2	6.9%
2021	9	31.0%
2022	3	10.3%
2023	2	6.9%
2024	2	6.9%
2025partial year	2	6.9%

Which technologies does Probiotical S.P.A. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 27

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 25

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 12

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 8

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 8

Y02A - Technologies FOR Adaptation TO Climate Change 7

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 4

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Probiotical S.P.A.'s patent record in context - here's where to go next.

Probiotical S.P.A.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 93.1% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #10,727 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Probiotical S.P.A. against PB Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.